Vera Therapeutics (VERA) Equity Income (2021 - 2024)
Vera Therapeutics posted quarterly Equity Income of -$7000.0 for Q2 2024, up 75.0% year-on-year from -$4000.0 in Q3 2023, and down 75.0% on a QoQ basis from -$4000.0 in Q1 2024.
Vera Therapeutics (VERA) has 4 years of Equity Income data on file, last reported at -$7000.0 in Q2 2024.
- For the quarter ending Q2 2024, Equity Income rose 75.0% year-over-year to -$7000.0; the trailing twelve-month figure through Jun 2024 stood at -$28000.0 (up 90.51% YoY), and the FY2023 full-year result was -$47000.0, up 94.19% from the prior year.
- Equity Income for Q2 2024 stood at -$7000.0, down from -$4000.0 in the prior quarter.
- Across five years, Equity Income topped out at -$1000.0 in Q1 2023 and bottomed at -$364000.0 in Q3 2021.
- The 4-year median for Equity Income is -$64000.0 (2022), against an average of -$135230.8.
- The widest annual swing landed in 2023, when Equity Income soared 99.65%; it then tumbled 300.0% in 2024.
- A 4-year view of Equity Income shows it stood at -$247000.0 in 2021, then soared by 74.09% to -$64000.0 in 2022, then surged by 96.88% to -$2000.0 in 2023, then slumped by 250.0% to -$7000.0 in 2024.
- The last three Equity Income figures came in at -$7000.0 (Q2 2024), -$4000.0 (Q1 2024), and -$2000.0 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 235,807.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Vera Therapeutics | 2.43 Bn | 1.83 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -7,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Dec 31, 2023 | -2,000.00 |
| Sep 30, 2023 | -15,000.00 |
| Jun 30, 2023 | -28,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Dec 31, 2022 | -64,000.00 |
| Sep 30, 2022 | -202,000.00 |
| Jun 30, 2022 | -256,000.00 |
| Mar 31, 2022 | -287,000.00 |
| Dec 31, 2021 | -247,000.00 |
| Sep 30, 2021 | -364,000.00 |
| Jun 30, 2021 | -281,000.00 |